1 / 96

Journey to Transplant: How Patients Facing Organ Failure Get on the Transplant Waiting List

Journey to Transplant: How Patients Facing Organ Failure Get on the Transplant Waiting List. Christine Lee, RN, BSN, CCTC Leeanne Shinn, RN UCLA Kidney and Pancreas Transplant Program. “How To Be”. Being in Action! The Answers Are In the Room “Report out” on Questions to Run-on: Scribe

padma
Télécharger la présentation

Journey to Transplant: How Patients Facing Organ Failure Get on the Transplant Waiting List

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Journey to Transplant:How Patients Facing Organ Failure Get on the Transplant Waiting List Christine Lee, RN, BSN, CCTC Leeanne Shinn, RN UCLA Kidney and Pancreas Transplant Program

  2. “How To Be” • Being in Action! • The Answers Are In the Room • “Report out” on Questions to Run-on: • Scribe • Spokesperson • All Teach / All Learn

  3. Question to Run on? • What can you do to educate your patients or community on the Journey to Transplant?

  4. Introductions • Christine Lee • Leeanne Shinn

  5. Objectives • Understand the referral, evaluation and listing process for organ transplant – kidney transplantation • Provide overview of the national wait list and review various deceased donor options • Discuss living donor transplant options

  6. Treatment Options • Heart/Lung/Liver failure: Organ transplant • Heart - LVAD as bridge to transplant • End stage renal disease (ESRD): • Dialysis • Kidney Transplant • Type 1 diabetes: • Insulin therapy • Pancreas alone (PA), kidney/pancreas transplant (SPK)

  7. What is the goal of kidney transplant? • Freedom from dialysis • Better quality of life • Prolongs life compared to dialysis • To maximize survival

  8. Fig. 1. Overall unadjusted actuarial survival probabilities for transplanted recipients and haemodialysis patients Mazzuchi, N. et al. Nephrol. Dial. Transplant. 1999 14:2849-2854; doi:10.1093/ndt/14.12.2849

  9. Kidney Transplant • Cons: • Not for everyone: compliance, health • Long wait time due to organ shortage • Require strict adherence to daily medications • Transplant medications for life

  10. Referral Process • For kidney transplant - Referral made by physician, dialysis social worker, insurance case manager or patient • Find a local transplant program • Necessary documents: • H&P, Social worker note, most recent lab, cardiac tests, imaging studies, ABO • Medicare Entitlement Form (2728 form) • Schedule an appointment with the transplant team for evaluation

  11. Selecting a Transplant Program • The experience of the transplant team • Insurance coverage • Geographical proximity to the program • The travel time to the transplant center is important when patient is waiting for an organ and is a key factor considered in organ distribution. • The quality and availability of pre- and post-transplant services. • Availability of friends and family for assistance

  12. Evaluation Process • Patient Education Orientation • Consultation with the transplant team • Transplant Physician • Surgeon • Transplant Nurse Coordinator • Social Worker • Dietician

  13. Evaluation Process • Other consultation as needed • Cardiology, Hepatology, Infectious Disease, Psychiatry, Hematology, Dermatology, Oncology, etc • Pending tests • Lab: Blood type x2, HLA, PRA, serology • Cardiac tests: EKG, Stress test, Echocardiogram, Coronary angiogram • Radiology: CXR, renal/abdominal ultrasound, CT scan, MRI • Screening tests: PSA, pap smear, mammogram, colonoscopy

  14. Patient Selection Criteria • Must be accepted as a candidate before listing • Selection Criteria • In general, all end-stage renal failure patients who, after having been informed of the risks of the transplant surgery and the inevitable chronic immunosuppressive therapy, still express a clear desire for this modality of treatment, will be accepted as candidates for evaluation. • Exclusion criteria • Presence of disseminated or recent malignancy • Active infection • Severe coronary artery disease and/or peripheral vascular disease • Underlying disease states such as multiple myeloma, scleroderma, oxalosis, sickle-cell anemia • Serious psychosocial problems • Squamous cell skin cancer • Renal cell carcinomas • BMI > 35 • Partial insurance coverage • Patients that are wheelchair bound, require oxygen, or are severely disabled • Patients who are unwilling to accept blood transfusions under any circumstances while taking anticoagulations

  15. Patient Selection Criteria • After completion of the workup, Selection Committee will review the case • The Committee is made up of Transplant Nephrologists, Surgeons, Nurse Coordinators, Social workers, dietician, pharmacist and other consultants • Once decision is made, the patient and physician will be notified in writing

  16. Listing Process • Medical clearance by the Selection Committee • Financial clearance • Eligibility for wait time accrual • On maintenance dialysis • GFR 20 or less • Notification within 10 days to the patient, physician and dialysis social worker

  17. UNOS Wait List • National Wait List - United Network for Organ Sharing (UNOS) • 107,337 patients are waiting for all organs • 84,000+ patients are waiting for kidney transplant

  18. U.S. Waiting List Candidates by Organs • Based on current OPTN data as reported on May 7, 2010. Data subject to change based on future data submission or correction.

  19. UNOS Wait List • About 16,000 transplants per year • 6,000 living donor transplant (doubled over 15 yrs) • 10,000 deceased donor • California Wait List • 16,250+ patients are waiting for kidney • Average wait time: 7 to 10 years

  20. Allocation Strategies • Dialysis Wait Time: • wait time starts as initial dialysis start date • Dual organ transplant • kidney/pancreas • Liver/Kidney • Heart/Kidney • Multiple listing

  21. Is there a way to reduce the waiting time? • Expanded Criteria Donor (ECD) kidney • A kidney from a donor age over 60 years or over age 50 with a history of HTN, cause of death due to CVA, or a terminal creatinine greater than 1.5 mg/d • Hepatitis C list • Only for the patients with hepatitis C • Donation after cardiac death (DCD) • A kidney from a donor who was declared dead based on a lack of a heartbeat. • These kidneys are less likely to function immediately & may have a greater risk of rejection • The Centers for Disease Control (CDC) increased risk • Higher risk for the transmission of viral disease including HIV & Hepatitis • Donation Point • Living Donor Transplant

  22. Living Donor Transplant Options Compatible Recipient-Donor pairs Desensitization Protocols Blood Type incompatible Kidney Exchange Program AKA Paired Exchange or Chain Transplant

  23. Living Donation • Related vs. Unrelated • Requirements • Age 18 ~ 65 • Health Concerns (diabetes, high blood pressure, cancer, hepatitis, weight issue) • Lifestyle: substance abuse

  24. Blood type compatibility chart Candidate’s Blood Type O A B AB Donor’s Blood Type O A or O B or O A, B, AB or O

  25. Compatible Recip-Donor Pairs • Blood types are compatible • Cross match testing indicates low risk of early rejection • Donor can donate directly to recipient

  26. But… What if the donor and the recipient are not compatible?

  27. At least one third of patients with a willing living donor are excluded due to incompatible blood type and positive cross match • 35% of any two people will be blood type incompatible • 30 % of patients needing a kidney transplant will be sensitized because of previous transplants, pregnancies or transfusions

  28. Desensitization • Advantages include increasing the donor pool and the friend or love one can donate to the intended recipient • Disadvantages include cost which averages approximately $30,000 • Decreased patient survival (5yr 87% vs. 94%) AJT 2004 • Unpredictable rates of accelerated rejection • Decreased graft survival (1yr. 84% vs. 96% ) AJT 2004 • Decreased 5 yr. graft survival (69% vs. 81%) AJT 2009

  29. Blood Type Incompatible • Living donor has different blood type • No other donor available • Requires analysis of antibody levels • Insurance authorization for treatment • Pre-operative treatment protocol over several weeks to achieve safe window for transplantation with your living donor

  30. ABOi • Molecules present or absent on blood cells determine blood type • When blood types are mixed, these molecules act as antigens that trigger ABO incompatibility reaction • Preconditioning is done to cleanse the blood of these circulating antibodies and depends on blood type and amount of antibodies present

  31. ABOi Therapies • Plasmapheresis- remove antibodies • Immunoglobulin-decrease antibodies which are destructive to the graft • Splenectomy • Anti-CD20 Antibody (rituximab)- depletes CD20 protein which is found on the wall of most B cells

  32. Paired Donation • Initially slow to take off because 1984 NOTA “unlawful to acquire organ in exchange for valuable consideration” • 2007 Senate bill “valuable consideration does not apply to paired donation”

  33. Donor Exchange • Recipient/donor pair have incompatible blood types • Other donor/recipient pair have incompatible blood types • Donors evaluated/accepted for donation • Donor/recipient pairs “exchange” donor kidneys • Exchange is anonymous until after surgery

  34. Pair #1 Recip blood type = A Donor blood type = B B to A is not compatible Pair #2 Recip blood type = B Donor blood type = A A to B is not compatible Paired donor exchange

  35. Paired Donor Exchange Pair #1 Pair #2 Recipient = A Recipient = B Donor = B Donor = A Blood-type incompatible Recip/Donor pairs exchange blood-type compatible kidneys

  36. Down Side of Paired Donation • If one living donor backs out then the other pair is disadvantaged • Requires simultaneous O.R. start

  37. Donor Exchange “Chains” • Participation of multiple pairs of donors and recipients • Usually started by a non-directed or “altruistic” • One donor is “left over” to begin a new section of the chain

  38. Donor Chains • Living donor can donate local to where they live • Kidneys are shipped using established OPO protocols on commercial flights • Do not need simultaneous O.R. start times

  39. Donor Chains • Very time intensive, high work load for low yield • Only about 120 done to date • Potential for 1,000 -2,000 additional kidney transplants per year • If there is a delay in donation, donor may back out

  40. In short, there are new options • “Standard” living donor transplant • Highly-sensitized • Blood-type incompatible • Paired or triple exchange • Donor exchange “chains”

  41. Conclusion • Timely referral to transplant center • Communication and collaboration between the referring physician, patient, dialysis unit and the transplant team are the key • Advances in living donation are providing patients with more opportunities for transplant

  42. Question to Run on? • What can you do to educate your patients or community on the Journey to Transplant? • 3 minutes to work at your tables and report back, Go!

  43. Transition to Breakout Session #2 Next Breakout Session starts at 11:30 Please see your agenda for specific room locations Enjoy the Learning!

  44. Journey to Transplant:How Patients Facing Organ Failure Get on the Transplant Waiting List Christine Lee, RN, BSN, CCTC Leeanne Shinn, RN UCLA Kidney and Pancreas Transplant Program

  45. “How To Be” • Being in Action! • The Answers Are In the Room • “Report out” on Questions to Run-on: • Scribe • Spokesperson • All Teach / All Learn

More Related